Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrisandra Shufelt

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cardiovascular Disorder and Medicine|March 13, 2023
Adenosine vs Regadenoson Pharmacologic Stress Differs in Women with Suspected Coronary Microvascular Dysfunction: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) StudyJanet Wei, Sawan Jalnakupur, Sherwin Dela Cruz, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
International Journal of Cardiology|July 26, 2018
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction studyOmeed Elboudwarej, Janet Wei, Navid Darouian, et al.
Journal of Cardiovascular Translational Research|February 27, 2026
Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood MicrosamplingPaul Marano, Kirstin Washington, Blandine Chazarin, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Circulation. Cardiovascular Imaging|March 25, 2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome EvaluationLouise E J Thomson, Janet Wei, Megha Agarwal, et al.
American Heart Journal Plus : Cardiology Research and Practice|July 5, 2022
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery diseaseOdayme Quesada, Omeed Elboudwarej, Michael D Nelson, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
International Journal of Cardiology. Heart & Vasculature|June 9, 2025
Parasympathetic response in women with coronary vascular dysfunction during mental stress compared to those with non-cardiac chest pain and reference controlsPuja K Mehta, Shafa-At A Sheikh, Esha K Dave, et al.
Maturitas|July 18, 2021
Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statementMargaret Rees, Johannes Bitzer, Antonio Cano, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cardiovascular Disorder and Medicine|March 13, 2023
Adenosine vs Regadenoson Pharmacologic Stress Differs in Women with Suspected Coronary Microvascular Dysfunction: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) StudyJanet Wei, Sawan Jalnakupur, Sherwin Dela Cruz, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
International Journal of Cardiology|July 26, 2018
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction studyOmeed Elboudwarej, Janet Wei, Navid Darouian, et al.
Journal of Cardiovascular Translational Research|February 27, 2026
Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood MicrosamplingPaul Marano, Kirstin Washington, Blandine Chazarin, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Circulation. Cardiovascular Imaging|March 25, 2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome EvaluationLouise E J Thomson, Janet Wei, Megha Agarwal, et al.
American Heart Journal Plus : Cardiology Research and Practice|July 5, 2022
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery diseaseOdayme Quesada, Omeed Elboudwarej, Michael D Nelson, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
International Journal of Cardiology. Heart & Vasculature|June 9, 2025
Parasympathetic response in women with coronary vascular dysfunction during mental stress compared to those with non-cardiac chest pain and reference controlsPuja K Mehta, Shafa-At A Sheikh, Esha K Dave, et al.
Maturitas|July 18, 2021
Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statementMargaret Rees, Johannes Bitzer, Antonio Cano, et al.
Pageof 11